Please note that the contents of this website are for corporate and non-commercial information purposes only, and are provided on the understanding that no surgical or medical
INEX or any of its subsidiary companies offers.
A Non Invasive Prenatal Diagnostic (NIPD) that isolates fetal cells in maternal blood, allowing for an unprecedented and definitive analyses of over 7,000 conditions in the fetus, as early as 10 weeks gestation.
COLLABORATING TO DELIVER MAXIMUM IMPACT
DROP US A LINE IF YOU THINK WE CAN WORK TOGETHER TO IMPROVE THE LIVES OF WOMEN AROUND THE WORLD.
At INEX INNOVATE we shake the diagnostics status quo and put scientific discoveries into clinical practice. These can never be achieved by working in silo. Partnerships are vital for continued medical advancements. We constantly seek collaborators to:
Support existing research and clinical programmes
Diversify our portfolio with new technology in women’s and reproductive health
Accelerate the development of innovative diagnostics tools based on cutting-edge technology
LICENSING AND TECHNOLOGY TRANSFER
We have a robust portfolio of global patents and licenses that can help bring fresh diagnostic solutions to new markets. Amidst rising healthcare needs, INEX INNOVATE comes ready with extensive medical, scientific and commercial know-how to apply our intellectual property to your market’s clinical practice. Contact us today to find out more.